Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSMA Expression Modulation in CSPC and CRPC in Response to Hormonal Therapy
NCT05919329Phase 4Recruiting
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jun 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started Jun 2024; status: recruiting.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05919329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919329.